- NEWS AND VIEWS
Dual-action obesity drug rewires brain circuits for appetite
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 629, 1011-1012 (2024)
doi: https://doi.org/10.1038/d41586-024-01352-6
References
Petersen, J. et al. Nature 629, 1133–1141 (2024).
Gabery, S. et al. JCI Insight 5, e133429 (2020).
Turcot, V. et al. Nature Genet. 50, 26–41 (2018).
Pechnick, R. N. et al. Neuropharmacology 28, 829–835 (1989).
Hall, K. D. Obesity 30, 11–13 (2022).
DiFeliceantonio, A. G. & Small, D. M. Nature Neurosci. 22, 1–2 (2019).
Wilding, J. P. H. et al. Diabetes Obes. Metab. 24, 1553–1564 (2022).
Competing Interests
The authors declare no competing interests.